Curaleaf Holdings, Inc.
Company Information
Industry
Medicinal Chemicals & Botanical Products
SIC Code
2833
Entity Type
other
SEC Category
Emerging growth company
State of Incorporation
British Columbia, Canada
Business Address
420 LEXINGTON AVENUE, NEW YORK, NY, 10170
Mailing Address
420 LEXINGTON AVENUE, NEW YORK, NY, 10170
Phone
781-451-0117
Fiscal Year End
1231
EIN
000000000
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 6-K Foreign company current report | April 3, 2026 | View on SEC |
| 6-K Foreign company current report | April 3, 2026 | View on SEC |
| 40-F Canadian company annual report | February 27, 2026 | View on SEC |
| 6-K Foreign company current report | February 27, 2026 | View on SEC |
| 6-K Foreign company current report | February 20, 2026 | View on SEC |
| 6-K Foreign company current report | February 20, 2026 | View on SEC |
| 6-K Foreign company current report | February 2, 2026 | View on SEC |
| 6-K Foreign company current report | January 21, 2026 | View on SEC |
| 6-K Foreign company current report | January 9, 2026 | View on SEC |
| 6-K Foreign company current report | January 5, 2026 | View on SEC |
Annual Reports
40-F
February 27, 2026
- International business revenue grew by a substantial 63% to $172.5 million for the full year 2025.
- Adjusted gross profit margin improved to 50% in 2025, up from 48.4% in 2024, reflecting better cost management.
Related Companies
Companies in the same industry (SIC: 2833)
MANNATECH INC
MTEX
Medicinal Chemicals & Botanical Products
Charlie's Holdings, Inc.
CHUC
Medicinal Chemicals & Botanical Products
Synergy CHC Corp.
SNYR
Medicinal Chemicals & Botanical Products
Tilray Brands, Inc.
TLRY
Medicinal Chemicals & Botanical Products
Target Group Inc.
CBDY
Medicinal Chemicals & Botanical Products
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.